BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25352244)

  • 1. Differences in quantitative assessment of myocardial scar and gray zone by LGE-CMR imaging using established gray zone protocols.
    Mesubi O; Ego-Osuala K; Jeudy J; Purtilo J; Synowski S; Abutaleb A; Niekoop M; Abdulghani M; Asoglu R; See V; Saliaris A; Shorofsky S; Dickfeld T
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):359-68. PubMed ID: 25352244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.
    Stirrat J; Joncas SX; Salerno M; Drangova M; White J
    J Cardiovasc Magn Reson; 2015 Aug; 17(1):66. PubMed ID: 26248535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of semi-automated scar quantification techniques using high-resolution, 3-dimensional late-gadolinium-enhancement magnetic resonance imaging.
    Rajchl M; Stirrat J; Goubran M; Yu J; Scholl D; Peters TM; White JA
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):349-57. PubMed ID: 25307896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy.
    Mikami Y; Kolman L; Joncas SX; Stirrat J; Scholl D; Rajchl M; Lydell CP; Weeks SG; Howarth AG; White JA
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):85. PubMed ID: 25315701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women's Interagency HIV Study.
    Kato Y; Kizer JR; Ostovaneh MR; Lazar J; Peng Q; van der Geest RJ; Lima JAC; Ambale-Venkatesh B
    BMC Med Imaging; 2021 Jul; 21(1):116. PubMed ID: 34315432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy.
    Tülümen E; Rudic B; Ringlage H; Hohneck A; Röger S; Liebe V; Kuschyk J; Overhoff D; Budjan J; Akin I; Borggrefe M; Papavassiliu T
    Heart Rhythm; 2021 Jun; 18(6):954-961. PubMed ID: 33515714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of late gadolinium enhancement image quality using a deep learning-based reconstruction algorithm and its influence on myocardial scar quantification.
    van der Velde N; Hassing HC; Bakker BJ; Wielopolski PA; Lebel RM; Janich MA; Kardys I; Budde RPJ; Hirsch A
    Eur Radiol; 2021 Jun; 31(6):3846-3855. PubMed ID: 33219845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation.
    Holtackers RJ; Van De Heyning CM; Nazir MS; Rashid I; Ntalas I; Rahman H; Botnar RM; Chiribiri A
    J Cardiovasc Magn Reson; 2019 Jul; 21(1):44. PubMed ID: 31352900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions.
    Spiewak M; Małek LA; Chojnowska L; Miśko J; Petryka J; Kłopotowski M; Milosz B; Polańska M; Ruzyłło W
    Int J Cardiovasc Imaging; 2010 Aug; 26(6):693-9. PubMed ID: 20349138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models.
    de Haan S; Meijers TA; Knaapen P; Beek AM; van Rossum AC; Allaart CP
    Heart; 2011 Dec; 97(23):1951-6. PubMed ID: 21917670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
    Flett AS; Hasleton J; Cook C; Hausenloy D; Quarta G; Ariti C; Muthurangu V; Moon JC
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):150-6. PubMed ID: 21329899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing a novel automatic 3D method for LGE-CMR quantification of scar size with established methods.
    Woie L; Måløy F; Eftestøl T; Engan K; Edvardsen T; Kvaløy JT; Ørn S
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):339-47. PubMed ID: 24249515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
    Zeidan-Shwiri T; Yang Y; Lashevsky I; Kadmon E; Kagal D; Dick A; Laish Farkash A; Paul G; Gao D; Shurrab M; Newman D; Wright G; Crystal E
    Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis.
    Gräni C; Eichhorn C; Bière L; Kaneko K; Murthy VL; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    J Cardiovasc Magn Reson; 2019 Feb; 21(1):14. PubMed ID: 30813942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.